Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
Clinical trial NCT05570058 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05570058
- Sponsor
- Redx Pharma Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-08
- Primary completion
- 2024-06-25
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.